arrow_back Trending Legislation
Share share

Pilot Program to Prevent Drugged Driving from Medications

This act establishes a two-year pilot program to raise public awareness about the dangers of driving under the influence of prescription and over-the-counter medications. The program will be implemented in states and territories most affected by the opioid epidemic to enhance road safety and protect citizens' lives.
Key points
A public marketing campaign will be created to educate drivers about the risks of driving after taking medications.
The pilot program will operate for two years in regions most impacted by opioid issues.
After the program concludes, the Secretary of Transportation will report on its results, potentially influencing future nationwide initiatives.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
RIDE Act of 2021
Print number: HR 888
Sponsor: Rep. Miller, Carol D. [R-WV-3]
Process start date: 2021-02-05
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Pilot Program to Prevent Drugged Driving from Medications

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 888.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-02-05.

What are the main provisions?

Key points include:

  • A public marketing campaign will be created to educate drivers about the risks of driving after taking medications.
  • The pilot program will operate for two years in regions most impacted by opioid issues.
  • After the program concludes, the Secretary of Transportation will report on its results, potentially influencing future nationwide initiatives.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Miller, Carol D. [R-WV-3].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Highways and Transit.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

Analysis and Potential Impact of HR 888

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Transport Health Security